top of page

Next-Generation PCR ONLINE: Applications of dPCR in liquid biopsy and cancer monitoring

Front Line Genomics
3/18/21, 7:00 PM
Europe/Berlin CET+2

Description

dPCR is particularly helpful in helping to quantify nucleic acids at a low frequency. With isolating ctDNA from a simple blood draw being likened to finding a needle in a haystack, improving our ability to detect these biomarkers in blood can improve the way we diagnose and monitor cancers forever.

 

This webinar will focus on the applications of dPCR in liquid biopsies, as well as future developments for these to be used routinely.

 

Ensuring the reliability of ctDNA results for clinical applications - Valerie Taly, Group Leader, INSERM

 

Circulating tumor DNA as an early on-treatment predictive biomarker for patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors – Ed Schuuring, Professor of Molecular Oncological Pathology, University Medical Centre Groningen

 

The implementation of dPCR in liquid biopsy and its considerations - Daniel Lofgren, Market Development Manager, Digital PCR, EMEA, QIAGEN

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

Ensuring the reliability of ctDNA results for clinical applications, Circulating tumor DNA as an early on-treatment predictive biomarker for patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors, The implementation of dPCR in liquid biopsy and its considerations

Inglês

Description

Speakers

Valerie Taly, Ed Schuuring, Daniel Lofgren

Speakers
Link to Event
Banner
Registro
bottom of page